Industry News
AusBiotech delegation of CEOs to Parliament House
AusBiotech’s CEO, a number of its directors and 20 of its member CEOs and executives will tomorrow be hosted at Parliament House for this year’s CEO Forum addressing issues in innovation policy and programs. [ + ]
Salt-resistant wheat developed by CSIRO
A salt-tolerant variety of durum wheat that outperforms other varieties by 25% on salty soils has been developed by CSIRO scientists using traditional crop breeding techniques. [ + ]
Salt tolerant wheat could boost yields by 25%
A new variety of salt tolerance durum wheat produced by Australian researchers could significant boost yields here and overseas and help farmers respond to climate change. [ + ]
Synchrotron solves clot-busting enzyme riddle
A century old puzzle of how a clot-busting protein, plasminogen, is activated in the body has been solved, possibly leading to new treatments for bleeding disorders and some cancers. [ + ]
TGA quarantines contaminated human albumin from CSL
Human albumin manufactured by CSL has been quarantined by the Therapeutic Goods Administration due to fears it may be contaminated with ethylene glycol. [ + ]
Australian-French Fellowship program for young scientists
The Australian Academy of Science and the Embassy of France today announced a new Fellowship program to help young Australian scientists work with cutting-edge French research institutions. [ + ]
Antihydrogen succumbs to spectroscopic measurement
CERN’s ALPHA collaboration has reported the first measurement of the antihydrogen spectrum. [ + ]
Australian Synchrotron discovers how plasminogen is activated in the body
Researchers at Monash University have used X-ray beams created by the Australian Synchrotron (AS) to discover how enzymes work to dissolve blood clots and clean up damaged tissue in the body - a finding that could ultimately lead to a reduction in the number of heart disease-related deaths occurring each year as a result of blood clots. [ + ]
Osprey Medical to raise $20m in IPO
Osprey Medical, a US-headquartered medical device company developing products based on Australian research, plans to list on the ASX via a $20m IPO. [ + ]
Latest AusBiotech journal features special medtech edition
AusBiotech is pleased to announce that the first edition for 2012 (March issue) of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a special medical technology edition. [ + ]
Minomic gets $5m investment funding
The Carnegie Innovation Fund has committed to invest up to $5 million in NSW-based prostate cancer diagnostic company Minomic International. [ + ]
Bionomics gains after All Ordinaries rebalance
Bionomics (ASX:BNO) shares grew 12.4% in two days after Standard & Poor's added the company to the S&P All Ordinaries index during its latest rebalance. [ + ]
Gorilla genome reveals closer connection to humans
Portions of the gorilla genome are closer to humans than we are to chimpanzees, shedding light on the evolution of our species. [ + ]
Sturdy Scandinavian conifers survived the ice age
A Murdoch University researcher has helped rewrite history after radiocarbon dating and genetic analysis proved that Scandinavian conifers in the high arctic survived the last ice age for several thousands of years. Until now, it was presumed that the Scandinavian landscape was devoid of trees during the ice age. [ + ]
Consortium converts water into chemical fuels
University of Wollongong scientists are behind the establishment of a global consortium which is using sunlight to convert water into important chemical fuels such as hydrogen gas. The research promises a significant reduction of greenhouse gas emissions by reducing CO2 from fossil fuel use. [ + ]